The albumin cobalt binding test: Analytical performance of a new automated chemistry assay for the detection of ischemia modified albumin (IMA™)

Journal of Clinical Ligand Assay

Volumn 25, Issue 2, 2002, Pages 178-187

  Fagan, Gary J ^a   Wayment, Hollie ^b   Morris, Deborah L ^b   Crosby, Peter A ^b  

^a Ischemia Technologies   (United States)

^b NONE

Author keywords

Albumin; Assay; Cobalt; Ischemia; Myocardial

Indexed keywords

ALBUMIN; BILIRUBIN; CARDIAC AGENT; CHOLESTEROL; COBALT; COBALT CHLORIDE; DITHIOTHREITOL; HEMOGLOBIN; HUMAN ALBUMIN; ISCHEMIA MODIFIED ALBUMIN; PROTEIN; TRANSITION ELEMENT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALBUMIN COBALT BINDING TEST; AMINO TERMINAL SEQUENCE; ARTICLE; ASSAY; AUTOMATION; CALIBRATION; COLORIMETRY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HEART MUSCLE ISCHEMIA; HUMAN; METAL BINDING; PERFORMANCE; PROTEIN MODIFICATION; QUANTITATIVE ASSAY; SENSITIVITY AND SPECIFICITY;

IMA;

EID: 0037633077     PISSN: 10811672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. AHA heart and stroke statistical update: American Heart Association 1999(Nov):www.americanheart.org
2. Graff LG, Dallara J, Ross MA, et al.: Impact on the care of the emergency department chest pain patient from the Chest Pain Evaluation Registry (CHEPER) Study. Am J Cardiol 1997;80:563-569.
3. Lawrence L, Hall MJ: 1997 summary: National Hospital Discharge Survey. Advanced data from vital and health statistics. National Center for Health Statistics 1999; No 308.
4. Rusnak RA, Stair TO, Hansen K, Fastow JS: Litagation against the emergency physician. Common features in cases of missed myocardial infarction. Ann Emerg Med 1989;18:1029-1034.
5. Storrow AB, Gibler WB: Chest pain centers: Diagnosis of acute coronary syndromes. Ann Emerg Med 2000;35:449-461.
6. Freiherr G: Cardiac markers: Developers enter a new era of progress. IVD Technology March/April 1998:36.
7. Alpert JS, Thygessen K, Antman E, Bassand JP, et al: Myocardial infarction redefined - A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000;36(3):382-392.
8. Kontos MC, Jesse. RL: Evaluation of the emergency department chest pain patient. Am J Cardiol 2000;85:32B-9B.
9. Gomez MA, Anderson JL, Karagounis LA, et al: An emergency department based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense. J Am Coll Cardiol 1996;28:25-33.
10. Bar-Or D, Lau E, Rao N, Bampos N, Winkler JV, Curtis CG: Reduction in the cobalt binding capacity of human albumin with myocardial ischemia [abstract]. Ann Emerg Med 1999;34:S56.
11. Bar-Or D, Lau E, Winkler JV: a novel marker for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emergency Med 2000;19:311-315.
12. Bar-Or D, Winkler JV, VanBenthuysen K, Harris L, Lau E, Hetzel FW: Reduced albumin cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronory angioplasty: A preliminary comparison to creatin kinase-MB, myoglobin, and troponin I. Am Heart J 2001;141(6):985-991.
13. Cobbe SM, Poole-Wilson PA: The time of onset and severity of acidosis in myocardial ischemia. J Mol Cell Cardiol 1980;12:745-760.
14. Levine RL: Ischemia: From acidosis to oxidation. FASEB J 1993;7:1242-1246.
15. Zweier JL: Measurement of superoxide-derived free radicals in the reperfused heart: evidence fora free radical mechanism of reperfusion injury. J Biol Chem. 1988;263:1353-1357.
16. rd ed. Philadelphia, W.B. Saunders Company, 1999, p 1808 (table).
17. Chevion M, Jiang Y, Har-El R, Berenshtein E, Uretzky G, Kitrossky N: Copper and iron are mobilized following myocardial ischemia: Possible predictive criteria for tissue injury. Proc Natl Acad Sci 1993;90:1102-1106.
18. Berenshtein E, Mayer B, Goldberg C: Kitrossky N, Chevion M: Patterns of mobilization of copper and iron following myocardial ischemia: Possible predictive criteria for tissue injury. J Mol Cell Cardiol 1997;29:3025-3034.
19. Lundgren J, Zhang H, Agardh CD, Smith ML, Evans PJ, Halliwell B, Siesjo BK: Acidosis-induced ischemic brain damage: Are free radicals involved? J. Cereb Blood Flow Metab 1991;11:4:587-596.
20. McCord JM: Oxygen derived free radicals in post-ischemic tissue injury: N Engl J Med 1985;312:159-163.
21. Wardman P, Candeias LP: Fenton Centennial Symposium. Fenton Chemistry: An Introduction. Radiation Research 1006;145:523-531.
22. Samuni A, Aronovitch J, Goldinger D, Chevion M, Czapski G: On the cytotoxicity of vitamin C and Metal ions. A Site-specific fenton mechanism. Eur J Biochem 1983;137:119-124.
23. Marx G, Chevion M: Site-specific modification of albumin by free radicals. Biochem J 1985;236:397-400.
24. 1H NMR spectroscopy. Biochemistry 1984;2831-2838.
25. Bal W, Christodoulou J, Sadler P, Tucker A: Multi-metal binding site of serum albumin. J Inorganic Biochem 1998;70:33-39.
26. Glennon JD, Sarkar B: Nickel (II) transport in human blood serum. Studies of nickel (II) binding to human albumin and to native-sequence peptide, and ternary-complex formation with L-histidine. Biochem J 1982;203:15-23.
27. Mohanakrishnan P, Chignell CF, Cox RH: Chloride ion nuclear magnetic resonance spectroscopy probe studies of copper and nickel binding to serum albumins. J Pharm Sci 1985;74:1:61-62.
28. Sokolowska M, Krezel A, Dyba M, Szewczuk Z, Bal W: Short peptides are not reliable models of thermodynamic and kinetic properties of the N-terminal metal binding site in serum albumin. Eur J Biochem 2002;269:1323-1331.
29. 2+ Binding Amino Acid Residues of the N-terminal Human Albumin. Eur J Biochem 2001;268:42-47.
30. Masuoka J, Hegenauer J, Van Dyke BR, Saltman P: Intrinsic stoichiometric equilibrium constants for the binding of zinc (II) and copper (II) to the high affinity site of serum albumin. J Biol Chem 1993;268:21533-21537.
31. 2+ binding by plasma albumin. Biochem Med 1974;9:177-183.
32. Williams GM, Olmsted III J, Breksa AP III: Coordination complexes of cobalt. J Chem Educ 1989;66:1043-1045.
33. Evaluation of Precision Performance of Clinical Chemistry Devices. National Committee for Clinical Laboratory Standards, Publication EP5-A, February 1999.
34. Painter PC, Branham E, Morris D, Wayment H, Lau E, Bar-Or D, Fagan G: Analytical Studies of an assay to detect myocardial ischemia [abstract]. Clinical Chemistry 2000;46(6):A75.
35. Chan B, Dodsworth N, Woodrow J, Tucker A: Harris R: Site specific N-terminus auto degradation of human serum albumin. Eur J Biochem 1995;227:524-528
36. Christenson RL, Duh SH, Sanhai, WR, Wu AHB, Holtman V, Painter P, Branham E, Apple FS, Murakami MA, Morris DL: Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: A multi-center study. Clinical Chemistry 2001;47:3:464-470.
37. Wu AHB, Morris DL, Flecher DR, Apple FS, Christenson RH, Painter PC: Analysis of the Albumin Cobalt Binding (ACB™) Test as an adjunct to cardiac troponin for the early detection of acute myocardial infarction. Cardiovascular Toxicology 2001;1:2:147-152.